CPS recombinant protein was intratumorally injected to B16F10 murine melanoma to stimulate the anti-tumor immune response mediated by strong CD8+ T cells, stimulate systemic anti-tumor immunity, and produce anti-tumor immune memory (Baird et al., 2013a). Here, CD8A is linked to neoplasm.